Revvity Income Statement
RVTY / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Revvity reported $2.9B in revenue and $241M in net income for FY2025. Revenue has grown at a 2.9% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.9B | $2.8B | $2.8B | $3.3B | $3.8B | $3.8B | $2.9B | $2.8B | $2.3B | $536.2M | $2.1B | $2.2B | $2.2B | $2.1B | $1.9B |
| Cost of Revenue | - | - | - | - | - | - | - | $1.4B | $708.7M | $664.8M | $696.5M | $708.0M | $783.6M | $763.0M | $686.8M |
| Gross Profit | - | - | - | $2.0B | $2.4B | $2.1B | $1.4B | $1.3B | $1.1B | $253.6M | $964.2M | $1.0B | $976.1M | $963.2M | $847.8M |
| SG&A Expense | $991.9M | $994.1M | $1.0B | $1.0B | $975.2M | $716.5M | $815.3M | $811.9M | $626.0M | $590.5M | $587.2M | $648.2M | $581.9M | $627.4M | $624.4M |
| R&D Expense | $215.8M | $196.8M | $216.6M | $221.6M | $200.3M | $146.4M | $189.3M | $194.0M | $139.5M | $124.2M | $112.5M | $108.1M | $132.4M | $131.8M | $115.8M |
| Operating Income | $356.6M | $346.7M | $300.6M | $742.7M | $1.3B | $867.3M | $362.0M | $323.9M | $295.6M | $294.6M | $250.9M | $165.0M | $227.8M | $103.1M | $91.1M |
| Interest Expense | - | - | - | - | - | $49.7M | $63.6M | $67.0M | $43.9M | $41.5M | $38.0M | $36.3M | $49.9M | $45.8M | $24.8M |
| Income Tax | $28.4M | $33.1M | $3.5M | $139.2M | $314.1M | $169.5M | $9.4M | $20.2M | $139.8M | $28.4M | $20.0M | -$6.3M | -$10.6M | -$16.1M | $63.2M |
| Net Income | $241.2M | $270.4M | $693.1M | $569.2M | $943.2M | $727.9M | $227.6M | $237.9M | $292.6M | $234.3M | $212.4M | $157.8M | $167.2M | $69.9M | $7.7M |
| EPS (Basic) | $5.56 | $4.51 | $8.12 | $6.52 | $2.06 | $2.15 | $2.67 | $2.14 | $1.89 | $1.40 | $1.49 | $0.61 | $0.07 | $3.34 | $0.71 |
| EPS (Diluted) | $5.55 | $4.50 | $8.08 | $6.49 | $2.04 | $2.13 | $2.64 | $2.12 | $1.87 | $1.39 | $1.47 | $0.61 | $0.07 | $3.31 | $0.70 |
| Shares Outstanding | 120.6M | 123.4M | 126.3M | 126.2M | 112.1M | 111.1M | 110.4M | 110.4M | 109.6M | 112.5M | 112.5M | 112.6M | 115.0M | 113.2M | 115.7M |
| Gross Margin | - | - | - | 60.1% | 63.6% | 55.8% | 48.4% | 48.3% | 47.6% | 47.3% | 45.8% | 44.9% | 45.2% | 45.5% | 44.2% |
| Operating Margin | 12.5% | 12.6% | 10.9% | 22.4% | 32.9% | 22.9% | 12.6% | 11.7% | 13.1% | 54.9% | 11.9% | 7.4% | 10.6% | 4.9% | 4.8% |
| Profit Margin | 8.5% | 9.8% | 25.2% | 17.2% | 24.6% | 19.2% | 7.9% | 8.6% | 13.0% | 43.7% | 10.1% | 7.0% | 7.8% | 3.3% | 0.4% |